Omeprazole [Design Issues]

posted by pash413 – India, 2012-12-06 19:09 (4935 d 11:04 ago) – Posting: # 9685
Views: 11,335

Dear all

One small confusion how to control last point Cmax in Fed BE study of prazole DR tablets. In some subjects Cmax is observed in last time points. Shall we exclude data of such subjects from final BE calculation?

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
142 visitors (0 registered, 142 guests [including 18 identified bots]).
Forum time: 07:13 CEST (Europe/Vienna)

Outside his own ever-narrowing field of specialization,
a scientist is a layman.
What members of an academy of science have in common
is a certain form of semiparasitic living.    Erwin Chargaff

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5